| Dr Sudesh Banaji, MD | |
|
332 E Cook St, Forrest City, AR 72335-2830 | |
| (870) 630-2233 | |
| (870) 630-2224 |
| Full Name | Dr Sudesh Banaji |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 332 E Cook St, Forrest City, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003815192 | NPI | - | NPPES |
| 5F219 | Other | AR | AR BCBS |
| 138381001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | E-2308 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest City Medical Center | Forrest city, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sudesh Banaji Md Pllc | 4486719879 | 2 |
News Archive
Tobacco and alcohol use may be the most common cause of head and neck cancers, but a new culprit has come on the scene in recent years.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
› Verified 6 days ago
| Entity Name | Sudesh Banaji Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659455830 PECOS PAC ID: 4486719879 Enrollment ID: O20090218000663 |
News Archive
Tobacco and alcohol use may be the most common cause of head and neck cancers, but a new culprit has come on the scene in recent years.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
› Verified 6 days ago
| Entity Name | Sudesh Banaji Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639319411 PECOS PAC ID: 4486719879 Enrollment ID: O20091009000319 |
News Archive
Tobacco and alcohol use may be the most common cause of head and neck cancers, but a new culprit has come on the scene in recent years.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sudesh Banaji, MD 332 East Cook Street, Forrest City, AR 72335-9183 Ph: (870) 630-2233 | Dr Sudesh Banaji, MD 332 E Cook St, Forrest City, AR 72335-2830 Ph: (870) 630-2233 |
News Archive
Tobacco and alcohol use may be the most common cause of head and neck cancers, but a new culprit has come on the scene in recent years.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
› Verified 6 days ago
Aaron Patrick Best, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 New Castle Rd, Forrest City, AR 72335 Phone: 870-261-0000 | |
Dr. Sudhir Kumar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Lindauer Rd, Forrest City, AR 72335 Phone: 870-633-5016 Fax: 870-633-6309 | |
Candace Danette Shafer- Franks, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Holiday Dr, Forrest City, AR 72335 Phone: 870-633-0880 | |
Miss Alisha Nichol Wyatt, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 529 N Gorman St, Forrest City, AR 72335 Phone: 870-633-9403 | |
Dr. Frank Rankin Schwartz Iii, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 902 Holiday Dr, Forrest City, AR 72335 Phone: 870-633-0800 Fax: 870-633-9086 | |
Nizar Chafik Issa, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 904 Holiday Dr, Forrest City, AR 72335 Phone: 870-630-9362 Fax: 870-630-9364 |